BioCentury | May 30, 2020
Finance

Daily Chart: May follow-on frenzy

...MyoKardia Inc. (NASDAQ:MYOK), Iovance Biotherapeutics Inc. (NASDAQ:IOVA) and bluebird bio Inc. (NASDAQ:BLUE). Medical devices company Boston Scientific...
BioCentury | Apr 17, 2020
Product Development

BARDA’s $483M commitment to Moderna headlines flurry of COVID-19 vaccine updates

...Sinovac Biotech Ltd. (NASDAQ:SVA) and Dynavax Technologies Corp. (NASDAQ:DVAX), and between Soligenix Inc. (NASDAQ:SNGX) and Boston Scientific...
...Tuesday, along with the Sinopharm unit of China National Biotech Group Corp. Soligenix gained from Boston Scientific’s...
...Writer and Sandi Wong, Assistant Editor mRNA-1273 Moderna Inc. Inovio Pharmaceuticals Inc. International Vaccine Institute Sinovac Biotech Ltd. Dynavax Technologies Corp. Soligenix Inc. Boston Scientific...
BioCentury | Dec 16, 2019
Company News

Architects behind Celgene takeout step down as Flagship adds another industry vet in Biondi

...James Gilbert, who was EVP of corporate strategy and BD, group president of cardiovascular at Boston Scientific...
BioCentury | Sep 16, 2019
Company News

Management tracks: Gottlieb joins FasterCures’ board; plus Foghorn, Varian

...Facchini was CMO and head of medical affairs for BTG Plc., which was acquired by Boston Scientific...
BioCentury | Nov 30, 2018
Company News

Boston Scientific to acquire London-based BTG

...venom. BTG plc (LSE:BTG), London, U.K. Boston Scientific Corp. (NYSE:BSX), Marlborough, Mass. Business: Cancer; Hematology Elizabeth S. Eaton Boston Scientific...
BioCentury | Sep 14, 2018
Company News

Boston Scientific to acquire Augmenix for $500M

...for $500 million in cash up front and up to $100 million in sales milestones. Boston Scientific...
...close next quarter. Augmenix Inc., Bedford, Mass. Boston Scientific Corp. (NYSE:BSX), Natick, Mass. Business: Cancer Shannon Lehnbeuter Augmenix Inc. Boston Scientific...
BioCentury | Oct 9, 2017
Politics & Policy

Patient engagement panel to focus on trial participation

...Companies listed on the agenda include AstraZeneca plc (LSE:AZN; NYSE:AZN), Johnson & Johnson Inc. (NYSE:JNJ), Boston Scientific...
BioCentury | Sep 8, 2017
Finance

Rig-ging an exit

...undisclosed milestones; and cardiovascular device play Symetis AG , which was acquired this year by Boston Scientific...
BioCentury | May 15, 2017
Company News

Duke-Margolis forms value-based payment consortium

...Companies funding the project include Allergan plc (NYSE:AGN), Amgen Inc. (NASDAQ:AMGN), bluebird bio Inc. (NASDAQ:BLUE), Boston Scientific...
...a framework designed to reduce healthcare costs (see BioCentury, April 27) . Chris Lieu Amgen Inc. bluebird bio Inc. Boston Scientific...
BioCentury | May 11, 2015
Financial News

Boston Scientific completes private placement of senior notes

Boston Scientific Corp. (NYSE:BSX), Natick, Mass. Business: Cardiovascular Date completed: 2015-05-07 Type: Private placement of senior notes Raised: $1.9 billion Investor: Existing investors Underwriters: Barclays Capital; Citigroup; Deutsche Bank; JPMorgan; BNP Paribas; Merrill Lynch, Pierce,...
Items per page:
1 - 10 of 427
BioCentury | May 30, 2020
Finance

Daily Chart: May follow-on frenzy

...MyoKardia Inc. (NASDAQ:MYOK), Iovance Biotherapeutics Inc. (NASDAQ:IOVA) and bluebird bio Inc. (NASDAQ:BLUE). Medical devices company Boston Scientific...
BioCentury | Apr 17, 2020
Product Development

BARDA’s $483M commitment to Moderna headlines flurry of COVID-19 vaccine updates

...Sinovac Biotech Ltd. (NASDAQ:SVA) and Dynavax Technologies Corp. (NASDAQ:DVAX), and between Soligenix Inc. (NASDAQ:SNGX) and Boston Scientific...
...Tuesday, along with the Sinopharm unit of China National Biotech Group Corp. Soligenix gained from Boston Scientific’s...
...Writer and Sandi Wong, Assistant Editor mRNA-1273 Moderna Inc. Inovio Pharmaceuticals Inc. International Vaccine Institute Sinovac Biotech Ltd. Dynavax Technologies Corp. Soligenix Inc. Boston Scientific...
BioCentury | Dec 16, 2019
Company News

Architects behind Celgene takeout step down as Flagship adds another industry vet in Biondi

...James Gilbert, who was EVP of corporate strategy and BD, group president of cardiovascular at Boston Scientific...
BioCentury | Sep 16, 2019
Company News

Management tracks: Gottlieb joins FasterCures’ board; plus Foghorn, Varian

...Facchini was CMO and head of medical affairs for BTG Plc., which was acquired by Boston Scientific...
BioCentury | Nov 30, 2018
Company News

Boston Scientific to acquire London-based BTG

...venom. BTG plc (LSE:BTG), London, U.K. Boston Scientific Corp. (NYSE:BSX), Marlborough, Mass. Business: Cancer; Hematology Elizabeth S. Eaton Boston Scientific...
BioCentury | Sep 14, 2018
Company News

Boston Scientific to acquire Augmenix for $500M

...for $500 million in cash up front and up to $100 million in sales milestones. Boston Scientific...
...close next quarter. Augmenix Inc., Bedford, Mass. Boston Scientific Corp. (NYSE:BSX), Natick, Mass. Business: Cancer Shannon Lehnbeuter Augmenix Inc. Boston Scientific...
BioCentury | Oct 9, 2017
Politics & Policy

Patient engagement panel to focus on trial participation

...Companies listed on the agenda include AstraZeneca plc (LSE:AZN; NYSE:AZN), Johnson & Johnson Inc. (NYSE:JNJ), Boston Scientific...
BioCentury | Sep 8, 2017
Finance

Rig-ging an exit

...undisclosed milestones; and cardiovascular device play Symetis AG , which was acquired this year by Boston Scientific...
BioCentury | May 15, 2017
Company News

Duke-Margolis forms value-based payment consortium

...Companies funding the project include Allergan plc (NYSE:AGN), Amgen Inc. (NASDAQ:AMGN), bluebird bio Inc. (NASDAQ:BLUE), Boston Scientific...
...a framework designed to reduce healthcare costs (see BioCentury, April 27) . Chris Lieu Amgen Inc. bluebird bio Inc. Boston Scientific...
BioCentury | May 11, 2015
Financial News

Boston Scientific completes private placement of senior notes

Boston Scientific Corp. (NYSE:BSX), Natick, Mass. Business: Cardiovascular Date completed: 2015-05-07 Type: Private placement of senior notes Raised: $1.9 billion Investor: Existing investors Underwriters: Barclays Capital; Citigroup; Deutsche Bank; JPMorgan; BNP Paribas; Merrill Lynch, Pierce,...
Items per page:
1 - 10 of 427